Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk
about
Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.Proprotein convertase subtilisin/kexin type 9 (PCSK9) in lipid metabolism, atherosclerosis and ischemic stroke.PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice.Postmenopausal hormone therapy: risks and benefits.Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation.
P2860
Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Exploring the interaction betw ...... therapy effects on stroke risk
@ast
Exploring the interaction betw ...... therapy effects on stroke risk
@en
type
label
Exploring the interaction betw ...... therapy effects on stroke risk
@ast
Exploring the interaction betw ...... therapy effects on stroke risk
@en
prefLabel
Exploring the interaction betw ...... therapy effects on stroke risk
@ast
Exploring the interaction betw ...... therapy effects on stroke risk
@en
P2093
P2860
P356
P1433
P1476
Exploring the interaction betw ...... therapy effects on stroke risk
@en
P2093
Dennis G Ballinger
Erica Beilharz
Jacques E Rossouw
Jennifer G Robinson
Randal D Robinson
Renee Stokowski
Ross L Prentice
Victor W Henderson
Ying Huang
P2860
P2888
P356
10.1186/GM358
P50
P577
2012-07-13T00:00:00Z
P5875
P6179
1038809173